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tissue plasminogen activator (tPA) expression by endothelial cells while levels of its inhibitor (PAI) are 
decreased by the drug. Apart from its fibrinolytic activity, PPS mobilise lipids through release of bound 
lipases, as well as SOD and platelet factor 4, from endothelial nd hepatic ells. Recent findings of decreased 
levels of osteocalcin in SF of PPS-treated OA patients uggests that osteoclast  activity may also be 
modulated by this drug, however this preliminary finding has yet to be confirmed. 
While disease modification in OA could be considered as the "Holy Grail" of rheumatology, many have 
questioned its reality. However, mounting data on the pharmacology of PPS suggests that we may shortly 
be in a position to challenge this dogma. 
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Disease modifying properties of sodium pentosan polysulphate (NaPPS) and insulin-like growth factor-1 
(IGF-1) in osteoarthritis (OA) were assessed in the Pond-Nuki canine cruciate deficiency model of OA. There 
were 5 groups of animals: N= unoperated controls; C = operated controls; PPS = intramuscular PPS, 2 mg/kg 
weeks 4 through 6; IGF-1 = intraarticular IGF-1 1 #g three times each week from week 4 through 6; 
PPS/ IGF-1  = both PPS and IGF-1 in the above regimen. At 6 weeks, femoral condylar cartilage was assessed 
for anatomy, histology (Mankin score) and biochemistry. 
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Results 
Anatomy: PPS/ IGF-1  approximated N.
Histology: PPS and PPS/ IGF-1  less severe than OA. 
Biochemistry: PPS had less enzyme than OA for active neutral metalloproteinase. PPS/ IGF-1  had near N 
active and total neutral metalloproteinase, tissue inhibitor of metalloproteinase, total 
collagenase, uronate and hydroxyproline. 
Conclusion 
NaPPS and particularly NaPPS combined with IGF-1 was able to interfere with the progression of OA in 
an animal model. It is hypothesized that proteinase activity was blocked by the NaPPS. The absence of 
effective proteinase activity is hypothesized to permit growth factor stimulation. 
Since it appears that a combination ofagents will be needed to effectively modify cartilage metabolism, this 
approach to therapeutics appears to be a rationale approach to disease modification i  OA. 
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Introduct ion 
In an established rabbit model of inflammatory arthritis induced by intra-articular injection of a hyaluronan 
poly-D-lysine complex (PC), calcium pentosan polysulphate (CaPPS, 10 mg/kg orally) demonstrated a 
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protective ffect on joint carti lage proteoglycan (PG) content (p < 0.0005) and biosynthesis as measured by 
3~S-PG specific activity (p < 0.0005) relative to carti lage of non-drug treated PC controls [1]. In the present 
investigation, the effects of CaPPS on the ex vivo metabolism of knee joint synovial fibroblasts (RSF) from 
the same model were also evaluated. 
Methods  
Ten rabbits were used for this study. Two remained untreated while the others had one knee joint injected 
with the PC complex 24 h before sacrifice. Commencing 8 days before sacrifice, four of the PC-treated rabbits 
were orally dosed every second day with 10 mg/kg CaPPS. At sacrifice, the synovium was dissected from each 
knee joint under sterile conditions and the RSF isolated and cultured. Cell lines (n = 20) were grown to the 
3rd passage and then frozen in liquid N2. Cells of 15 lines were plated at equal densities and incubated for 
24 h ± interleukin-l(IL-1). Ex  vivo production of nitric oxide (NO) in culture was determined as nmoles 
nitrite/pg DNA in RSF media using the Griess reagent [2]. IL-6 in media was assayed by proliferation of 7TD1 
cells [3] and RSF DNA content determined by proteinase K digestion and fluorescence after binding to 
Hoechst 33258 dye [4]. 
Resu l ts  
In RSF derived from non-PC injected joints, addition of 40 pg/ml IL-1 in vitro caused a significant decrease 
in cellular DNA content (0.24 + 0.02 to 0.18 ___ 0.01 pg DNA/well, p < 0.05), an increase in NO production 
(3.03 ± 0.25 to 5.71 ± 0.45 nmol/#g DNA, p < 0.02) and an increase in IL-6 activity (17.0 ,,, 2.0 to 
124 __+ 18 pg/#g DNA, p < 0.05). In contrast, in RSF derived from inflamed synovium of PC-injected joints, 
DNA content was already significantly reduced compared to the non-PC controls (0.16 _± 0.01 pg DNA/well, 
p < 0.02). Furthermore, NO production (4.17 ___ 0.16 nmol/pg DNA) and IL-6 activity (105 ± 17 pg//~g DNA) 
were significantly increased in these PC-RSF compared to  non-PC controls (p < 0.05). The addition of 
40 pg/ml IL-1 to these cell cultures did not cause additional changes in the measured parameters. 
RSF isolated from PC joints of rabbits treated with CaPPS exhibited DNA contents, NO production and IL-6 
activities imilar to RSF from non-PC joints of control animals. Moreover, the addition of 40 pg/ml IL-1 to 
RSF cultures from PCjo ints  of CaPPS treated animals maintained DNA content (0.25 ± 0.02 pg/well) above 
non-PC RSF levels. Although NO production was not significantly altered, IL-6 activity (85 ± 9 pg/pg DNA) 
stimulated by the presence of IL-1 was significantly lower in RSF from PC joints of CaPPS-treated animals 
compared to IL-6 activity (151 __+ 12 pg/#g DNA) in cells from PC joints of non-drug treated rabbits (p < 0.02). 
Conc lus ion  
These data show that in vitro RSF derived from inflamed (PC) joints respond differently to exposure to IL-1 
than RSF from non-inflamed control joints. However, pretreatment of animals with oral CaPPS provided 
protection to RSF by modulating the deleterious effects of IL-1 on synovial cell functions, including 
proliferation and production of NO and IL-6. On the basis of these findings we conclude that CaPPS protects 
carti lage PGs both directly and via modulation of synovial cell release of NO and cytokines. 
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Both cartilage and subchondral bone are implicated in the pathogeny of osteoarthrosis (OA). Aggrecan 
synthesis rates and the capability of secreting large aggrecan aggregates are diminished in cartilage of 
